SpectRx/Welch Allyn Cervical Cancer Detection PMA Expected By 2002
This article was originally published in The Gray Sheet
Executive Summary
Premarket approval application submission for a non-invasive cervical cancer detection system co-developed by SpectRx and Welch Allyn will occur in late 2001 or early 2002, SpectRx says.